Professor Paul Fletcher

A Psychedelic Conversation: Tackling the Taboo

Antonina Kouli and Bart Nieuwenhuis report on the CamBRAIN panel discussion of psychedelic drugs’ medical potential As strange as it sounds today, psychedelic drugs like LSD and psilocybin (magic mushrooms’ active ingredient) showed great clinical promise in the early 1960s. Several early scientific papers suggested that psychedelics could be used to treat psychiatric disorders and even for pain relief. However, the simultaneous rise in psychedelic use by the public at

Understanding the Irrational

Laura Nunez-Mulder discusses psychiatry’s future with Professor Paul Fletcher Psychiatry is changing. Historically, the field has been dynamic, undergoing transformation as institutions and asylums have come in and out of fashion. Over the last century, the Diagnostic and Statistical Manual of Mental Disorders (DSM), a handbook of checklists by which psychiatrists can make diagnoses, has been overhauled time and time again. The DSM is a controversial manual. Many disorders overlap,